Cipla Seeks Shareholder Nod for New Global CEO and Board Changes via Postal Ballot

Cipla Ltd ( (IN:CIPLA) ) has provided an announcement.

Cipla has initiated a postal ballot process to seek shareholder approval for key board and management changes, including the appointment of Achin Gupta as a director, and as managing director and global chief executive officer, along with approval of his remuneration. The company is also seeking to re-appoint P R Ramesh as an independent director, with shareholders voting electronically between 24 February and 25 March 2026, underscoring a significant leadership transition that could shape Cipla’s strategic direction and governance framework.

The postal ballot notice, dated 23 January 2026, is being circulated electronically to shareholders whose email addresses are registered as of the specified cut-off date, while others are urged to update their contact details. Results of the e-voting are expected by 30 March 2026, and the documentation has been made available on Cipla’s website, stock exchange portals and the National Securities Depository’s e-voting platform, ensuring transparency and broad investor access to the decision-making process.

More about Cipla Ltd

Cipla Ltd is a leading Indian pharmaceutical company headquartered in Mumbai, producing a wide range of generic and branded medicines for domestic and international markets. The company focuses on therapies including respiratory, anti-infective, cardiovascular and other chronic segments, and its shares are listed on major Indian exchanges as well as in Luxembourg.

Average Trading Volume: 109,557

Technical Sentiment Signal: Hold

Current Market Cap: 1089.8B INR

See more insights into CIPLA stock on TipRanks’ Stock Analysis page.